Green Thumb Q4 revenue up 5.7%, beats estimates

Green Thumb Industries

25/02/2026 21:23

Overview

Cannabis goods firm's Q4 revenue rises 5.7%, beating analyst expectations

Net income for Q4 was significantly higher due to fair value adjustments

Company repurchased 2 mln shares for $14.1 mln

Outlook

Company expects Q1 2026 revenue to decline mid-single digits due to pricing pressure

Green Thumb anticipates 2026 capital expenditures to be approximately $80 million

Company increased credit facility by $50 million for enhanced financial flexibility

Result Drivers

MINNESOTA LAUNCH - Revenue growth in Q4 driven by adult-use cannabis sales launch in Minnesota

RETAIL EXPANSION - Increased expenses due to opening and operation of new retail stores

PRICE COMPRESSION - Gross profit decline due to price compression and increased competition

Company press release: ID:nGNXbqgFNl

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Beat
$311.10 mln
$296.09 mln (8 Analysts)
Q4 Net Income
$83.20 mln
Q4 EBITDA
$75.30 mln
Q4 Gross Profit
$141.30 mln
Q4 Operating Cash Flow
$90 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the drug retailers peer group is "buy"

Wall Street's median 12-month price target for Green Thumb Industries Inc is C$18.50, about 104.2% above its February 24 closing price of C$9.06

The stock recently traded at 49 times the next 12-month earnings vs. a P/E of 44 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)